Endocrine Testing Market Outlook, Trends And Future Opportunities (2024-2031)

Endocrine Testing Market Outlook, Trends And Future Opportunities (2024-2031)

Endocrine Testing Market, By Product Type (Assay Kits and Reagents, Analyzers, Software and Services, Others (Consumables, Accessories)), By Technology (Immunoassay, Tandem Mass Spectrometry, ELISA, Clinical Chemistry, Others (Radioimmunoassay, Sensor-Based Assays)), By Disease Type (Diabetes, Thyroid Disorders, Growth Hormone Disorders, Reproductive Disorders, Adrenal Disorders, Bone and Mineral Disorders, Others (Pituitary Disorders, Parathyroid Disorders)), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Research Institutes, Others (Home Care Settings, Ambulatory Care Centers)), By Test Type (Thyroid Tests, Fertility Tests, Diabetes Tests, Growth Hormone Tests, Others (Adrenal Tests, Bone and Mineral Tests)), By Sample Type (Blood, Urine, Saliva, Others (Tissue, Cerebrospinal Fluid)), By Mode (Centralized Testing, Point-of-Care Testing, Others (Direct-to-Consumer Testing)), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Apr 2024
  • Author(s): Sagar Karlekar
  • Report ID: IDA130
  • Region: Global
  • Format: PDF/EXCEL

Table Of Contents:

  • Chapter 1. Research Methodology and Scope
    • Market Segmentation and Scope
    • Regional Coverage
    • Objectives
    • Research Methodology
  • Chapter 2. Executive Summary
    • Market Landscape
    • Market Size & Forecast
    • Competitive Landscape
  • Chapter 3. Endocrine Testing Market: By Product Type Market Trends, Size, and Future Outlook
    • By Product Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Product Type Definitions, Technology Landscape
    • By Product Type Market Drivers
      • Product Launches
      • Technology Launches
    • By Product Type Market Restraints
  • Chapter 4. Endocrine Testing Market: By Technology Market Trends, Size, and Future Outlook
    • By Technology Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Technology Definitions, Technology Landscape
    • By Technology Market Drivers
      • Product Launches
      • Technology Launches
    • By Technology Market Restraints
  • Chapter 5. Endocrine Testing Market: By Disease Type Market Trends, Size, and Future Outlook
    • By Disease Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Disease Type Definitions, Technology Landscape
    • By Disease Type Market Drivers
      • Product Launches
      • Technology Launches
    • By Disease Type Market Restraints
  • Chapter 6. Endocrine Testing Market: By End-User Market Trends, Size, and Future Outlook
    • By End-User Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By End-User Definitions, Technology Landscape
    • By End-User Market Drivers
      • Product Launches
      • Technology Launches
    • By End-User Market Restraints
  • Chapter 7. Endocrine Testing Market: By Test Type Market Trends, Size, and Future Outlook
    • By Test Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Test Type Definitions, Technology Landscape
    • By Test Type Market Drivers
      • Product Launches
      • Technology Launches
    • By Test Type Market Restraints
  • Chapter 8. Endocrine Testing Market: By Sample Type Market Trends, Size, and Future Outlook
    • By Sample Type Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Sample Type Definitions, Technology Landscape
    • By Sample Type Market Drivers
      • Product Launches
      • Technology Launches
    • By Sample Type Market Restraints
  • Chapter 9. Endocrine Testing Market: By Mode Market Trends, Size, and Future Outlook
    • By Mode Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Mode Definitions, Technology Landscape
    • By Mode Market Drivers
      • Product Launches
      • Technology Launches
    • By Mode Market Restraints
  • Chapter 10. Endocrine Testing Market: Regional Market Trends, Size, and Future Outlook
    • North America
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
        • Market Size (US$), CAGR (%), and Forecast (2021-2031)
        • Definitions, Technology Landscape
        • Market Drivers
          • Product Launches
          • Technology Launches
          • Write Any Such Market Drivers Based on previous information
        • Market Restraints
        • Competitive Outlook
    • Europe
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
        • Market Size (US$), CAGR (%), and Forecast (2021-2031)
        • Definitions, Technology Landscape
        • Market Drivers
          • Product Launches
          • Technology Launches
          • Write Any Such Market Drivers Based on previous information
        • Market Restraints
        • Competitive Outlook
    • Asia Pacific
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
        • Market Size (US$), CAGR (%), and Forecast (2021-2031)
        • Definitions, Technology Landscape
        • Market Drivers
          • Product Launches
          • Technology Launches
          • Write Any Such Market Drivers Based on previous information
        • Market Restraints
        • Competitive Outlook
    • Latin America
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
        • Market Size (US$), CAGR (%), and Forecast (2021-2031)
        • Definitions, Technology Landscape
        • Market Drivers
          • Product Launches
          • Technology Launches
          • Write Any Such Market Drivers Based on previous information
        • Market Restraints
        • Competitive Outlook
    • Middle East, and Africa
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
        • Market Size (US$), CAGR (%), and Forecast (2021-2031)
        • Definitions, Technology Landscape
        • Market Drivers
          • Product Launches
          • Technology Launches
          • Write Any Such Market Drivers Based on previous information
        • Market Restraints
        • Competitive Outlook
  • Chapter 11. Endocrine Testing Market: Competitive Landscape
    • Roche Diagnostics
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Abbott Laboratories
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Siemens Healthineers
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Danaher Corporation
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Thermo Fisher Scientific
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Becton, Dickinson and Company (BD)
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Bio-Rad Laboratories
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Sysmex Corporation
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • DiaSorin S.p.A.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Quidel Corporation
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • bioMérieux SA
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Ortho Clinical Diagnostics
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Beckman Coulter, Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Randox Laboratories Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Fujirebio Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Wallac Oy
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Tosoh Corporation
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Merck KGaA
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Autobio Diagnostics Co., Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies

Research Methodology

    • Primary Research
    • Secondary Research
    • Assumptions
    • IDataAcumen Analysis
    • Paid Databases

Appendix

    • About Us

Frequently Asked Questions

The current market size of the Endocrine Testing industry is USD 4.2 billion.

Rising prevalence of endocrine disorders, Increasing geriatric population, Technological advancements in diagnostics, Growing awareness about preventive care, Increasing healthcare expenditure, Favorable reimbursement policies, Adoption of advanced diagnostic technologies, Increasing focus on early disease detection, 9) Urbanization, 10) Changing dietary patterns.

High cost of advanced diagnostics, Stringent regulatory policies, Lack of skilled professionals, Reimbursement issues, Limited access to healthcare in developing regions, Lack of awareness and education, Challenges in disease diagnosis and management.

The leading component segment in the Endocrine Testing Market is the assay kits and reagents segment, which includes diagnostic tests for accurate hormone measurement.

Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Sysmex Corporation, DiaSorin S.p.A., Quidel Corporation, bioMérieux SA, Ortho Clinical Diagnostics, Beckman Coulter, Inc., Randox Laboratories Ltd., Fujirebio Inc., Wallac Oy, Tosoh Corporation, Merck KGaA, Autobio Diagnostics Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

The North America region is expected to lead the Endocrine Testing Market, with a market size of USD 8.5 billion by 2031 and a CAGR of 9.2% from 2024 to 2031.

Rising prevalence of endocrine disorders, Increasing geriatric population, Technological advancements in diagnostics, Growing awareness about preventive care, Increasing healthcare expenditure, Favorable reimbursement policies, Adoption of advanced diagnostic technologies, Increasing focus on early disease detection.